Quercetin Promotes Abdominal Aortic Aneurysm Regression Through the RAGE/PI3K/AKT/mTOR Axis

被引:0
|
作者
Yang, Xin [1 ]
Wang, Ying [1 ]
Xin, Guangyu [1 ]
Li, Jie [1 ]
Xu, Lei [1 ]
Zhang, Guohua [2 ]
Yang, Haotian [2 ]
机构
[1] Qiqihar Med Univ, Affiliated Hosp 2, Qiqihar 161006, Peoples R China
[2] Heilongjiang Acad Agr Sci, Branch Anim Husb & Vet Branch, Qiqihar, Peoples R China
关键词
quercetin; RAGE; abdominal aortic aneurysm; elastase; RAGE/PI3K/AKT/mTOR; SUPPRESSES; THERAPY; CANCER; RAGE;
D O I
10.1177/1934578X241286438
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: Abdominal aortic aneurysms (AAA) are a common critical cardiovascular disease with high morbidity and mortality rates. Quercetin, a flavonoid and a traditional Chinese medicinal ingredient commonly found in vegetables and fruits, has a favorable inhibitory effect on experimental aneurysms without side effects. This study aimed to model elastase AAA and investigate the mechanism of action of quercetin in alleviating AAA. Methods: Quercetin was administered at a dose of 60 mg/kg once daily starting on the day of AAA induction for 5 weeks. The therapeutic effect of quercetin on AAA was demonstrated using biochemical assays, observation of pathological tissue sections, Elastic Van Gieson staining, immunohistochemistry, molecular docking simulations, and Western blot protein validation. Results: Our study showed that quercetin treatment significantly alleviated abdominal aortic vessel wall dilatation, elastin degradation and adhesion to surrounding tissues caused by elastase. Additionally, quercetin significantly inhibited the mRNA and protein expression of the receptor for advanced glycation end products(RAGE)/ phosphatidylinositol 3-kinase (PI3K)/ phosphatidylinositol 3-kinase (AKT) / mammlian target of rapamycin (mTOR) pathway. Conclusion: Quercetin can alleviate abdominal aortic injury caused by elastase via RAGE/PI3K/AKT/mTOR and provide experience in clinical use.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies
    Barrett, David
    Brown, Valerie I.
    Grupp, Stephan A.
    Teachey, David T.
    PEDIATRIC DRUGS, 2012, 14 (05) : 299 - 316
  • [22] The PI3K/Akt/mTOR signaling pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2011, 22 : 19 - 19
  • [23] PI3K/AKT/mTOR pathway in angiogenesis
    Karar, Jayashree
    Maity, Amit
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2011, 4
  • [24] TMAO promotes dementia progression by mediating the PI3K/Akt/ mTOR pathway
    Hu, Xiaojuan
    Zhang, Yamin
    Gu, Cheng
    Wu, Ruipeng
    Yao, Yuping
    Gao, Fulin
    Luo, Lulu
    Zhang, Yi
    TISSUE & CELL, 2023, 81
  • [25] KIRREL promotes the proliferation of gastric cancer cells and angiogenesis through the PI3K/AKT/mTOR pathway
    Wang, Tao
    Chen, Shuo
    Wang, Ziliang
    Li, Siyu
    Fei, Xichang
    Wang, Tong
    Zhang, Mingjun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (01)
  • [26] APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway
    Wang, Qi
    Wang, Bingyu
    Zhang, Wenjing
    Zhang, Teng
    Liu, Qingqing
    Jiao, Xinlin
    Ye, Jinwen
    Hao, Yiping
    Gao, Qun
    Ma, Guangzhen
    Hao, Chunyan
    Cui, Baoxia
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 755
  • [27] Overview of the PI3K/Akt/mTOR pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2008, 19 : 21 - 21
  • [28] The PI3K/AKT/mTOR interactive pathway
    Ersahin, Tulin
    Tuncbag, Nurcan
    Cetin-Atalay, Rengul
    MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1946 - 1954
  • [29] LGR6 promotes the progression of gastric cancer through PI3K/AKT/mTOR pathway
    Ke, Jing
    Ma, Peng
    Chen, Jinpeng
    Qin, Jun
    Qian, Haixin
    ONCOTARGETS AND THERAPY, 2018, 11 : 3025 - 3033
  • [30] TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway
    Gao, Xiang
    Jiang, Wenqu
    Ke, Zunliang
    Huang, Qiwei
    Chen, Liang
    Zhang, Guobin
    Li, Chao
    Yu, Xiaojun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 586 : 34 - 41